Algorae Pharmaceuticals Limited ASX: 1AI Share Price & Review

1AI Overview

1AI Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Weak

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About 1AI

Website

Algorae Pharmaceuticals Limited

Telephone

64.9.276.2690

Address

Unit 107 23 Edwin Street Mount Eden, Auckland 1024

Description

Algorae Pharmaceuticals Ltd. is a biotechnology company, which engages in the development of treatments for implanting healthy living cells to replace or repair diseased or damaged organs for life threatening diseases. The company was founded by Robert Bartlett Elliot and David Collinson in 1987 and is headquartered in Mount Eden, New Zealand.

1AI Price Chart

Key Stats

Market Cap

AU$11.81M

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.0 - 0.01

Trade Value (12mth)

AU$3,458.00

1 week

1 month

YTD

-30%

1 year

-46.15%

All time high

0.59

Key Fundamentals

EPS 3 yr Growth

-45.80%

EBITDA Margin

N/A

Operating Cashflow

-$2m

Free Cash Flow Return

-45.00%

ROIC

-61.80%

Interest Coverage

N/A

Quick Ratio

17.90

Other Data

Shares on Issue (Fully Dilluted)

1687m

HALO Sector

Healthcare

Next Company Report Date

N/A

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

1AI Announcements

Latest Announcements

Date	Announcements
21 November 24	24 New AI-Generated Drug Targets × 24 New AI-Generated Drug Targets
18 November 24	Algorae Discontinues Legacy OTCQB AD Share Program × Algorae Discontinues Legacy OTCQB AD Share Program
18 November 24	Proposed issue of securities - 1AI × Proposed issue of securities - 1AI
28 October 24	Notification regarding unquoted securities - 1AI × Notification regarding unquoted securities - 1AI
28 October 24	Appendix 3Y x2 × Appendix 3Y x2
25 October 24	AGM Chairman Address to Shareholders × AGM Chairman Address to Shareholders
25 October 24	Results of Meeting × Results of Meeting
25 October 24	Proposed issue of securities - 1AI × Proposed issue of securities - 1AI
23 October 24	Quarterly Activities Report /Appendix 4C Cash Flow Statement × Quarterly Activities Report /Appendix 4C Cash Flow Statement
24 September 24	AlgoraeOS Artificial Intelligence Platform Launched × AlgoraeOS Artificial Intelligence Platform Launched
23 September 24	Notice of Annual General Meeting/Proxy Form × Notice of Annual General Meeting/Proxy Form
06 September 24	Date of AGM and Closing Date for Director Nominations × Date of AGM and Closing Date for Director Nominations
02 September 24	Notification of cessation of securities - 1AI × Notification of cessation of securities - 1AI
30 August 24	Annual Report and Appendix 4E × Annual Report and Appendix 4E
30 August 24	Appendix 4G and Corporate Governance Statement × Appendix 4G and Corporate Governance Statement
31 July 24	Positive results from AI-116 in vitro studies × Positive results from AI-116 in vitro studies
22 July 24	Quarterly Activities Report /Appendix 4C Cash Flow Statement × Quarterly Activities Report /Appendix 4C Cash Flow Statement
01 July 24	Change of Company Secretary × Change of Company Secretary
16 May 24	Application for quotation of securities - 1AI × Application for quotation of securities - 1AI
16 May 24	Cleansing Notice × Cleansing Notice
09 May 24	Change of Company Secretary × Change of Company Secretary
30 April 24	Application for quotation of securities - 1AI × Application for quotation of securities - 1AI
30 April 24	Cleansing Notice × Cleansing Notice
29 April 24	Quarterly Activities Report /Appendix 4C Cash Flow Statement × Quarterly Activities Report /Appendix 4C Cash Flow Statement
26 April 24	Application for quotation of securities - 1AI × Application for quotation of securities - 1AI

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Falling Divs over next 2

Values and Recommendations

Key Stats

Consensus Score

Recommendation

EPS 1 month Change

Quality Yield

Falling Divs over next 2

Halo Consensus Score

PEG Ratio

Consensus EPS Revisions

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

1AI Shortsell

Frequently Asked Questions

What is the current share price of Algorae Pharmaceuticals Limited (1AI:ASX)?

The current share price of Algorae Pharmaceuticals Limited (1AI:ASX) is AU$0.007.

What is the 52-week high share price for Algorae Pharmaceuticals Limited (1AI:ASX)?

The 52-week high share price for Algorae Pharmaceuticals Limited (1AI:ASX) is AU$0.01.

What is the 52-week low share price for Algorae Pharmaceuticals Limited (1AI:ASX)?

The 52-week low share price for Algorae Pharmaceuticals Limited (1AI:ASX)? is AU$0.00.

What is the dividend yield for Algorae Pharmaceuticals Limited (1AI:ASX)?

Algorae Pharmaceuticals Limited (1AI:ASX) does not pay a dividend.

What was Algorae Pharmaceuticals Limited (1AI:ASX) last dividend payment?

Algorae Pharmaceuticals Limited (1AI:ASX) does not pay a dividend.

What is the franking level for Algorae Pharmaceuticals Limited (1AI:ASX)?

Algorae Pharmaceuticals Limited (1AI:ASX) has a franking level of 0.0%.

In which sector is Algorae Pharmaceuticals Limited (1AI:ASX) classified?

Algorae Pharmaceuticals Limited (1AI:ASX) is classified in the Healthcare.

The current P/E ratio for Algorae Pharmaceuticals Limited (1AI:ASX) is .

Company

Important

Get the latest insights and hot tips delivered right to your inbox

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.

1AI · ASX

Algorae Pharmaceuticals Limited (ASX:1AI)

AU$0.007

1AI Overview

1AI Health Scores

About 1AI

1AI Price Chart

Key Stats

AU$11.81M

N/A

N/A

Dividends Overview

N/A

N/A

N/A

Market Data

Key Fundamentals

Other Data

1AI Announcements

Latest Announcements

24 New AI-Generated Drug Targets

Algorae Discontinues Legacy OTCQB AD Share Program

Proposed issue of securities - 1AI

Notification regarding unquoted securities - 1AI

Appendix 3Y x2

AGM Chairman Address to Shareholders

Results of Meeting

Proposed issue of securities - 1AI

Quarterly Activities Report /Appendix 4C Cash Flow Statement

AlgoraeOS Artificial Intelligence Platform Launched

Notice of Annual General Meeting/Proxy Form

Date of AGM and Closing Date for Director Nominations

Notification of cessation of securities - 1AI

Annual Report and Appendix 4E

Appendix 4G and Corporate Governance Statement

Positive results from AI-116 in vitro studies

Quarterly Activities Report /Appendix 4C Cash Flow Statement

Change of Company Secretary

Application for quotation of securities - 1AI

Cleansing Notice

Change of Company Secretary

Application for quotation of securities - 1AI

Cleansing Notice

Quarterly Activities Report /Appendix 4C Cash Flow Statement

Application for quotation of securities - 1AI

Dividends

Key Stats

N/A

N/A

N/A

N/A

Values and Recommendations

Key Stats

Halo Consensus Score

PEG Ratio

Consensus EPS Revisions

Short selling

Key Stats

0.00%

0

N/A

N/A

N/A

N/A

Discover Short-sellingOpportunities

1AI Shortsell

Related Companies

Frequently Asked Questions

Company

Company

Important

Discover
Short-selling
Opportunities